tradingkey.logo

Viatris rises after quarterly results beat estimates

ReutersAug 7, 2025 11:58 AM

Shares of generic drugmaker Viatris VTRS.O rise 3.9% to $9.09 premarket

VTRS posts Q2 adj. profit of 62 cents per share compared with analysts' estimate of 56 cents - data compiled by LSEG

Its quarterly revenue came in at $3.58 billion vs estimates of $3.47 billion

Company reaffirms its 2025 revenue forecast to be between $13.5 billion and $14 billion

Also reaffirms its annual adj. profit per share to be between $2.16 and $2.30

Up to last close, stock was down 29.7% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI